Ilan Bio

Ilan Bio is a plant biotechnology company specializing in the development of elite genetics for the medical cannabis and hemp industries. The company leverages a proprietary platform that integrates micropropagation (advanced tissue culture) with CRISPR-Cas9 gene-editing technology to produce disease-free, genetically uniform, and chemically consistent plant clones. These standardized genetics are designed to meet rigorous pharmaceutical-grade standards, ensuring purity and stability for plant-derived therapeutics. Operating facilities in both California and Israel, Ilan Bio aims to optimize cannabinoid and terpene profiles to support the global biopharmaceutical supply chain for botanical medicines. The company bridges the gap between traditional agricultural practices and modern biotechnological manufacturing requirements.